What is Real-World Data (RWD) in Healthcare? | Definition & Guide
Real-world data in healthcare refers to clinical, claims, and operational data collected during routine care delivery and health system operations — as opposed to data generated within the controlled protocols of clinical trials. RWD sources include electronic health records (Epic, Cerner, Oracle Health), insurance claims databases, patient registries, pharmacy dispensing records, medical device telemetry, wearable sensors, and death registries. The distinction between real-world data and real-world evidence is fundamental: RWD is the raw input; real-world evidence is the analytical output produced when RWD is curated, analyzed, and interpreted to answer specific clinical or regulatory questions. Flatiron Health, Tempus, IQVIA, and Komodo Health operate large-scale RWD platforms that aggregate, normalize, and link data across sources to create research-grade datasets for biopharma, regulators, payers, and health systems.
Definition
Real-world data in healthcare refers to clinical, claims, and operational data collected during routine care delivery and health system operations, as opposed to data generated within the controlled protocols of clinical trials. RWD sources include electronic health records (Epic, Cerner, Oracle Health), insurance claims databases, patient registries, pharmacy dispensing records, medical device telemetry, wearable sensors, and death registries. The distinction between RWD and real-world evidence is fundamental: RWD is the raw input; real-world evidence (RWE) is the analytical output produced when RWD is curated, analyzed, and interpreted to answer specific clinical, commercial, or regulatory questions.
Why It Matters
The value of RWD depends entirely on its quality, completeness, and fitness for the intended use case. The healthcare industry generates massive volumes of clinical and administrative data, but most of that data was captured for clinical documentation or billing purposes — not for research or analytics. An EHR progress note written to support a clinical encounter contains valuable clinical information, but extracting structured, research-grade endpoints (disease progression, treatment response, adverse events) from unstructured narrative text requires specialized technology and domain expertise.
This gap between data availability and data usability is where companies like Flatiron Health, Tempus, and IQVIA operate. Flatiron curates oncology RWD by combining technology-enabled abstraction (including LLM-based extraction) with human clinical expert review, transforming unstructured EHR notes into structured datasets with defined endpoints. IQVIA aggregates claims, EHR, and prescription data across millions of patients to create longitudinal datasets that span care settings and data types. Komodo Health links disparate data sources to create comprehensive longitudinal patient records across care settings.
For biopharma companies, RWD supports multiple strategic functions: identifying eligible patient populations for clinical trial recruitment, generating external control arms for single-arm trials, conducting post-market safety surveillance, supporting health economics and outcomes research for payer negotiations, and informing commercial strategy through treatment pattern analysis. For payers and health systems, RWD enables population health analytics, quality benchmarking, and value-based contract performance tracking.
The regulatory environment is accelerating RWD adoption. The FDA's RWE framework, CMS's increasing reliance on quality data from EHRs, and payer demands for evidence-based formulary management all drive investment in RWD infrastructure. But the "garbage in, garbage out" principle applies forcefully: RWD-derived insights are only as reliable as the data curation, linkage, and validation processes that prepare raw data for analysis.
How It Works
RWD in healthcare operates across a pipeline from raw data capture to research-ready datasets:
-
Data capture at the point of care — Clinical staff generate RWD through routine documentation: EHR notes, order entries, lab results, imaging reports, medication administration records, and procedure documentation. This data is captured primarily for clinical and billing purposes, not research. The format varies — structured fields (diagnosis codes, lab values, medication lists) coexist with unstructured narrative text (progress notes, radiology reports, pathology findings) — and quality depends on documentation practices that vary by clinician, specialty, and institution.
-
Claims data generation — Insurance claims data is generated when services are billed to payers. Claims capture diagnoses (ICD-10), procedures (CPT/HCPCS), medications (NDC codes), facility information, and payment amounts. Claims data is highly structured and available at scale but has inherent limitations: it captures what was billed, not what was clinically observed; it includes diagnostic codes assigned for billing purposes that may not reflect clinical reality; and claims data latency (30-90 days) limits real-time utility. Claims-driven analytics provide broad population-level patterns but lack the clinical depth of EHR data.
-
Data linkage and deidentification — Research-grade RWD often requires linking data across sources — connecting a patient's EHR records to their claims history, pharmacy dispensing data, and mortality records to create a longitudinal view. Linkage uses probabilistic or deterministic matching algorithms based on demographic identifiers, then deidentifies the linked dataset to comply with HIPAA Safe Harbor or Expert Determination requirements. Datavant operates a widely used health data linking infrastructure that enables cross-dataset matching while maintaining deidentification.
-
Data normalization and enrichment — Raw RWD from different sources uses different coding systems, data formats, and clinical terminologies. Normalization maps disparate data elements to common ontologies (SNOMED CT for clinical concepts, RxNorm for medications, LOINC for lab tests) so that "metformin 500mg" from one source and "Glucophage 500mg" from another are recognized as the same medication. Enrichment adds derived variables: calculating time-to-treatment, defining treatment lines in oncology, or flagging disease progression events from sequential lab values and imaging reports.
Real-World Data and SEO/AEO
Real-world data in healthcare is searched by biopharma data strategy leaders, HEOR directors, chief data officers at health systems, and regulatory affairs professionals evaluating RWD sources, data quality frameworks, and platform capabilities. We target RWD terminology through our healthcare SEO practice because content about real-world data must distinguish between data availability and data usability — addressing curation methodology, linkage infrastructure, and fitness-for-purpose validation rather than simply describing data sources. This audience evaluates content based on whether it demonstrates understanding of the technical and methodological challenges that determine whether RWD produces credible evidence or misleading analysis.